Rennovia, JM Davy Team To Promote Biobased Glucaric And Adipic Acid Production Technology
Rennovia Inc., a Menlo Park, Calif.-based developer of cost-advantaged biobased chemical production processes — and Johnson Matthey Davy Technologies Ltd. (JM Davy) — a London-based developer and licensor of proprietary chemical process technologies — have announced a collaboration under which they will develop, demonstrate and commercialize catalytic process technologies for biobased glucaric and adipic acid production.
The collaboration involves use of Rennovia’s catalytic aerobic oxidation technology to convert glucose to glucaric acid and the catalytic hydrogenation of glucaric acid to adipic acid. The companies aim to develop and jointly license a package of technologies that will enable the two chemicals to be produced on a commercial scale.
Adipic acid, traditionally derived from petroleum, is used in the production of nylon 6,6 fibers and engineering resins, polyesters, polyurethanes, and other applications. Rennovia’s technology, using renewable carbohydrate materials including corn sugars and eventually cellulosic glucose products, enables production of adipic acid at 20- to 25-percent lower costs than petroleum-based adipic acid, with an 85-percent projected reduction in greenhouse gas emissions.
Glucaric acid, derived from glucose, is a precursor of adipic acid in Rennovia’s biobased process. It also can be used in detergent, antifreeze, cement and anticorrosion applications.
“With their extensive experience developing and licensing catalytic process technologies across a wide range of biobased and petrochemical markets, Rennovia considers JM Davy an ideal development and licensing partner for our renewable glucaric acid and adipic acid products,” said Robert Wedinger, president and CEO, Rennovia. “We look forward to working with JM Davy to deliver technologies to the marketplace that are scalable, less capital-intensive, and cost-advantaged over current petrochemical processes.”
March 25, 2014